Report Preview

Global Intravenous Infusion Pump Market By Types (Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA), Implantable Infusion Pumps) By Application (Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology) By End User (Hospitals & Clinics, Home Healthcare) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2031.

In 2021, the market for Intravenous Infusion Pump worldwide was worth $ 4.8 billion US dollars. The market will reach US$ 8.9 billion by 2031, growing at a CAGR of 8.3 percent between 2022 and 2031.

Market Dynamics

In Intravenous Infusion Pump Market there is an increasing incidences of chronic diseases, along with rapid growth noticed in the geriatric population. A study report by WHO shows that the percentage of the global population, over 60 years, will double its rate from 12% to 22% between 2015- 2050 expecting a rise in the geriatric population. Increasing number of ambulatory infusion pumps and the rising number of people undergoing surgical procedures are some other driving factors leading to the market. Intravenous infusion pumps are mostly used in the administration of critical fluids that include high-risk medication. Most of the infusion pumps are equipped with safety features & in-built alarms for the operator alerts, intended to activate in the event of emergency. Many disease conditions like deficiencies, immune cancer, and congestive heart failure require infusion pump therapy.

Accordingly, Infusion pumps offers various advantages over manual administration of medicated fluids such as the ability to deliver fluids in very small volumes. However, it also offers to deliver fluids at precise process or automated intervals. Therefore, these techniques remain highly adopted by healthcare systems. Moreover, the product recalls and infusion pumps malfunctions like software defects & user interface issues are the major growth restraining factors for the market to hamper the growth of the Intravenous Infusion Pump which may restrain the market growth.

COVID Impact

The COVID-19 pandemic had a negative impact on the intravenous infusion pump market. As COVID-19 spread increased around the globe in 2020, intensive care units (ICU) started to fill up with patients who were critically ill from the virus. As COVID-19 patients began to increase in hospital ICUs, infusion pump stocks quickly dropped down. A surge in orders was required from supplier’s, pressurizing on them to manufacture more to fulfill the demand. As per the article in 2021 under the title “Comparative Analysis of Intravenous Pumps Relocation for Critically Ill Isolated COVID-19 Patients from Bedside to Outside the Patient Room”, after the relocation of intravenous pumps from inside to outside the patient room, there was a considerable decrease in COVID-19 exposure based on the frequency of new entries.

Regional Trend

Geographically, North America dominated the Intravenous Infusion Pump market and had the largest revenue share of 49.7% in 2022. The growth in this region can be attributed to due to the rising incidences of chronic diseases coupled with rising number of surgical procedures performed. A well-developed and increasing R&D and escalating adoption of technological advancement in infusion pumps contributed to the growth the of intravenous pumps industry in this region. The U.S. held the biggest market share of the North America intravenous infusion market due to rise in disease prevalence, huge medical R&D investments and a strong healthcare system. The prevalence of diabetes in the U.S. is also a key significant factor, which can be attributed to their lifestyle & stressed work environment.

Asia Pacific region is expected to witness a significant growth of 8.5% over the forecast period. Asian countries are densely populated with an increasing burden of chronic diseases like cardiovascular illnesses, diabetes, and cancer. Asian countries like Japan, China and India are developing economies with well-developed healthcare infrastructure and facilities.

Competitive Landscape

Key players operating in the Intravenous Infusion Pump Market include B. Braun Holding GmbH & Co. KG, Baxter International, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, CareFusion Corporation, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, ICU Medical, Inc., IRadimed Corporation, Medtronic, Micrel Medical Devices SA, Mindray, Moog Inc., Smith Medical, Tandem Diabetes Care, Inc., and Terumo Corporation among others. In May 2018, Baxter International launched SpectrumIQ, an infusion pump technology with integrated EMR (Electronic Medical Records), & DeviceVue, an asset tracking software to improve the efficiency of drug delivery.

Key USP’s-

One of the key factors driving competitiveness among market players is the shift in technology, automation, standardized dosing, and the extensive adoption of advanced healthcare technology for better healthcare services. However, major players often opt for geographical expansion to retain market share and adopt strategies such as mergers, acquisitions, and new product launches to widen their product portfolio.

Market Segmentation

Based upon the Types of pumps used in the Intravenous Infusion Pump market is segmented in Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia (PCA) and Implantable Infusion Pumps. The Volumetric infusion pumps dominated the Intravenous Infusion Pumps market in 2022 with a market share of 16.7% of the total segments. Volumetric infusion pumps held the largest market share in 2022 as these pumps are having the capacity of delivering continuous and very specific amounts of fluids at very slow to very fast rates. Based on the application, the Intravenous Infusion Pump market is segmented into Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology and Hematology. In the application segment the most dominant market is pediatrics /neonatology which covered the largest Intravenous Infusion Pumps market share of 26.5% in 2022. This segment is driven by the treatment for pediatrics with advanced technology and with the rising number of births worldwide, the demand for effective pediatric care has also grew.

End user segment of Intravenous Infusion Pump market is further bifurcated into Hospitals & Clinics and Home Healthcare. The hospitals & clinics segment held major share of the global market in 2021. Demand for medical equipment, including Intravenous Infusion Pumps, due to availability of smart and advanced intravenous infusion pumps in hospitals along with rise in prevalence of chronic diseases and increased healthcare expenditure.

By Type

• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps
• Patient Controlled Analgesia (PCA)
• Implantable Infusion Pumps

By Application

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology

By End User

• Hospitals & Clinics
• Home Healthcare